These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 34934300)

  • 1. Pemphigus Vulgaris Localized to the Scalp with Complete Response to Topical Steroids.
    Vega-Diez D; Lario AR; Zubiaur AG; Medina S
    Int J Trichology; 2021; 13(6):36-38. PubMed ID: 34934300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cutaneous pemphigus vulgaris. A case report].
    Bello C; Mondaca-Cornejo L; Navarrete-Dechent C; González S
    Rev Med Chil; 2013 Apr; 141(4):525-30. PubMed ID: 23900375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pemphigus chronicus vulgaris--case report].
    Spoljar S; Cavka M; Tvorić A
    Acta Med Croatica; 2012 Oct; 66 Suppl 1():41-7. PubMed ID: 23193820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pemphigus vulgaris with circulating anti-desmoglein 3 and anti-BP180 antibodies: a case report and brief review of cases with coexistence of pemphigus vulgaris and bullous pemphigoid.
    Cassano N; Mastrandrea V; Tampoia M; Filotico R; Vestita M; Vena GA
    J Biol Regul Homeost Agents; 2009; 23(3):197-201. PubMed ID: 19828097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pemphigus vulgaris with loss of hair on the scalp.
    Hadayer N; Ramot Y; Maly A; Zlotogorski A
    Int J Trichology; 2013 Jul; 5(3):157-8. PubMed ID: 24574698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cutaneous type pemphigus vulgaris: a rare clinical phenotype of pemphigus.
    Yoshida K; Takae Y; Saito H; Oka H; Tanikawa A; Amagai M; Nishikawa T
    J Am Acad Dermatol; 2005 May; 52(5):839-45. PubMed ID: 15858475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Response of ocular pemphigus vulgaris to therapy. Case report and review of literature.
    Olszewska M; Komor M; Mazur M; Rogozinski T
    J Dermatol Case Rep; 2008 Mar; 2(1):1-3. PubMed ID: 21886701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of intravenous immunoglobulin (IVIG) affinity-purified anti-desmoglein anti-idiotypic antibodies in the treatment of an experimental model of pemphigus vulgaris.
    Mimouni D; Blank M; Payne AS; Anhalt GJ; Avivi C; Barshack I; David M; Shoenfeld Y
    Clin Exp Immunol; 2010 Dec; 162(3):543-9. PubMed ID: 20964642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Case Report: Autoimmune Pemphigus Vulgaris in a Patient Treated With Cemiplimab for Multiple Locally Advanced Cutaneous Squamous Cell Carcinoma.
    Buquicchio R; Mastrandrea V; Strippoli S; Quaresmini D; Guida M; Filotico R
    Front Oncol; 2021; 11():691980. PubMed ID: 34540666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cutaneous pemphigus vulgaris with skin features similar to the classic mucocutaneous type: a case report and review of the literature.
    Shinkuma S; Nishie W; Shibaki A; Sawamura D; Ito K; Tsuji-Abe Y; Natsuga K; Chan PT; Amagai M; Shimizu H
    Clin Exp Dermatol; 2008 Nov; 33(6):724-8. PubMed ID: 18627395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mucosal and mucocutaneous (generalized) pemphigus vulgaris show distinct autoantibody profiles.
    Ding X; Aoki V; Mascaro JM; Lopez-Swiderski A; Diaz LA; Fairley JA
    J Invest Dermatol; 1997 Oct; 109(4):592-6. PubMed ID: 9326396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deep pemphigus (pemphigus vulgaris, pemphigus vegetans and paraneoplastic pemphigus) in dogs, cats and horses: a comprehensive review.
    Tham HL; Linder KE; Olivry T
    BMC Vet Res; 2020 Nov; 16(1):457. PubMed ID: 33228633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-lasting Localized Pemphigus Vulgaris without Detectable Serum Autoantibodies Against Desmoglein 3 and Desmoglein 1.
    Yoshifuku A; Fujii K; Kawahira H; Katsue H; Baba A; Higashi Y; Aoyama Y; Kanekura T
    Indian J Dermatol; 2016; 61(4):427-9. PubMed ID: 27512189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pemphigus--paradigm of autoantibody-mediated autoimmunity.
    Hertl M; Veldman C
    Skin Pharmacol Appl Skin Physiol; 2001; 14(6):408-18. PubMed ID: 11598441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mucocutaneous pemphigus vulgaris carrying high-titre antidesmoglein 1 antibodies with skin lesions resembling pemphigus erythematosus.
    Cirillo N; Santoro R; Lanza M; Annese P; Gombos F; Lanza A
    Clin Exp Dermatol; 2008 Jan; 33(1):32-5. PubMed ID: 17983457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Desmoglein 3-ELISA: a pemphigus vulgaris-specific diagnostic tool.
    Lenz P; Amagai M; Volc-Platzer B; Stingl G; Kirnbauer R
    Arch Dermatol; 1999 Feb; 135(2):143-8. PubMed ID: 10052398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Case of pemphigus foliaceus which occurred after five years of remission from pemphigus vulgaris.
    Kimoto M; Ohyama M; Hata Y; Amagai M; Nishikawa T
    Dermatology; 2001; 203(2):174-6. PubMed ID: 11586021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Explanations for the clinical and microscopic localization of lesions in pemphigus foliaceus and vulgaris.
    Mahoney MG; Wang Z; Rothenberger K; Koch PJ; Amagai M; Stanley JR
    J Clin Invest; 1999 Feb; 103(4):461-8. PubMed ID: 10021453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pemphigus vulgaris associated with silicosis.
    Yamagami Y; Kohda M; Mimura S; Ueki H
    Dermatology; 1998; 197(1):55-7. PubMed ID: 9693188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The extent of desmoglein 3 depletion in pemphigus vulgaris is dependent on Ca(2+)-induced differentiation: a role in suprabasal epidermal skin splitting?
    Spindler V; Endlich A; Hartlieb E; Vielmuth F; Schmidt E; Waschke J
    Am J Pathol; 2011 Oct; 179(4):1905-16. PubMed ID: 21864491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.